CC BY-NC-ND 4.0 · The Arab Journal of Interventional Radiology 2020; 04(03): S5
DOI: 10.1055/s-0041-1729012
Abstract

Percutaneous Mechanical Athero-Thrombectomy Using the Rotarex®S Device in Peripheral Artery In-Stent Restenosis or Occlusion: A French Retrospective Multicenter Study on 128 Patients

Romaric Loffroy
François-Mitterrand University Hospital, Dijon, France
,
Gilles Goyault
Clinique De L’Orangerie, Strasbourg, France
,
Alain Chabanier
Centre Hospitalier de la Côte Basque, Bayonne, France.
,
Jean-Marc Pernes
Hôpital Privé d’Antony, Paris, France
,
Antoine Sauguet
Clinique Pasteur, Toulouse, France
,
Olivier Chevallier
François-Mitterrand University Hospital, Dijon, France
,
Nicolas Olivier
François-Mitterrand University Hospital, Dijon, France
,
Marco Midulla
François-Mitterrand University Hospital, Dijon, France
,
Nizam Edriss
Centre Hospitalier Artois-Ternois, Arras, France
› Author Affiliations
 

    Objectives: To ascertain the safety and mid-term outcomes of Rotarex®S rotational atherectomy plus thrombectomy device (Straub Medical AG, Wangs, Switzerland) with or without adjunctive treatment (e.g., percutaneous transluminal angioplasty [PTA]/drug-coated balloon [DCB]/stenting) in patients with in-stent restenosis (ISR) or occlusion in the iliac and/or infrainguinal arteries. Methods: This was a French multicenter retrospective study of all patients treated by in-stent percutaneous mechanical debulking (PMD) of the lower limbs with Rotarex®S device between January 2013 and November 2018. Results: The cohort consisted of 128 patients (88 men and 40 women), aged 39–94 years (median, 66.7 years). All patients presented with cardiovascular risk factors. Overall, 51.5% of the patients had critical limb ischemia. The study demonstrated a technical success of 96.9% in the population with PMD and adjunctive PTA (95/128, 74.2%) or adjunctive DCB (16/128, 12.5%) or both (13/128, 10.2%). At 12-month follow-up, the primary patency rate was 92.3% and the secondary patency rate was 91.4%. The rate of limb salvage was 93.7%. We accounted for 32 (25%) re-interventions with mean time from Rotarex®S treatment to re-intervention of 7.1 ± 8.2 months. Target lesion revascularization (TLR) was 19.5% (25/128). Seven (5.5%) patients developed distal embolism that responded to endovascular treatment. At mean follow-up, major adverse events observed were death (18/128, 14.1%), myocardial infarction (9/128, 7.0%), stroke (2/128, 1.6%), and renal failure (3/128, 2.3%). Conclusion: Recanalization with Rotarex®S rotational atherectomy plus thrombectomy device is a treatment of choice for arterial ISR/occlusions of the iliac and/or infrainguinal arteries, regardless of the age of the thrombus, with satisfying TLR. Only adjunctive PTA is often necessary to further improve the recanalization.


    #

    Address for correspondence

    Romaric Loffroy
    François-Mitterrand University Hospital
    France   

    Publication History

    Article published online:
    26 April 2021

    © 2020. The Arab Journal of Interventional Radiology. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial-License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/).

    Thieme Medical and Scientific Publishers Pvt. Ltd.
    A-12, 2nd Floor, Sector 2, Noida-201301 UP, India